Company Original BioMedicals Co., Ltd.

Equities

6483

TW0006483001

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 03:30:00 07/06/2024 am IST 5-day change 1st Jan Change
15.9 TWD -0.93% Intraday chart for Original BioMedicals Co., Ltd. +9.28% -12.15%

Business Summary

Original BioMedicals Co Ltd is a Taiwan-based company mainly engaged in the development of new drugs with non-new ingredients, and the provision of related research and development services, especially focusing on drugs with new dosage forms, new dosages, new indications and innovative controlled release systems. The Company is engaged in the research and development, design, production and sales of new nanocomposite microcell-based drugs. Products include OBM-B01 for cyanide detoxification and lung protection, OBM-CL for antibiotic infection treatment, radiation injury prevention drug OBM-A01, and OBM-Iron Dextran for improving the formulation and manufacturing process of iron dextran. The Company's products are mainly sold domestically.

Number of employees: 20

Sales per Business

TWD in Million2022Weight2023Weight Delta
New Drug Research and Development
100.0 %
0 100.0 % 0 100.0 % -59.81%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
0 100.0 % 0 100.0 % -59.81%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 65,550,000 20,283,550 ( 30.94 %) 0 30.94 %

Company contact information

Original BioMedicals Co., Ltd.

6F No. 415, Section 2, Tiding Boulevard

114 92, Taipei

+

http://www.i-obm.com
address Original BioMedicals Co., Ltd.(6483)
  1. Stock Market
  2. Equities
  3. 6483 Stock
  4. Company Original BioMedicals Co., Ltd.